 As of 2017, Galenika controlled around 10% of market share in Serbia.In November 2017, Luxembourg's investment fund Aelius (related to the Brazilian largest pharmaceutical company EMS) purchased 93.73% of the company's shares from the Government of Serbia for a total of 16 million euros.From 1945, Galenika has changed four different logos.